2017, Number 3
Next >>
Rev Latin Infect Pediatr 2017; 30 (3)
Chickenpox: «It is a benign disease»
Hernández PM, Castillo BJI
Language: Spanish
References: 9
Page: 91-92
PDF size: 168.10 Kb.
Text Extraction
No abstract.
REFERENCES
Hernández PM. Varicela en vacunación: niños, adolescentes, adultos e inmunocomprometidos. Ed. Medicina, Publicidad y Mercadotecnia S.A. de C.V, Cd. Mx., México 2017; 129-139.
Thomas CA, Shwe T, Bixler D, del Rosario M, Grytdal S, Wang C et al. Two-dose varicella vaccine effectiveness and rash severity in outbreaks of varicella among public school students. Pediatr Infect Dis J. 2014; 33 (11): 1164-1168.
Sistema Único Nacional de Vigilancia Epidemiológica. Dirección General de Epidemiología.
Hamborsky J, Kroger A, Wolfe S. Epidemiology and prevention of vaccine-preventable diseases. 13th edition. Washington D.C.: Public Health Foundation; 2015.
Cabrera-Gaytán DA, Muñoz-Mendoza W, Gómez-Altamirano CM. Comportamiento epidemiológico de la varicela en México: 18 años de estudios y estimaciones para los próximos 5 años. Rev Enfer Infec Pediatr. 2009; 22.23 (87): 77-82.
Rev Panam. Salud Pública/Pan Am J Public Health. 2002; 12 (2).
Hirose M, Gilio AE, Ferronato AE, Ragazzi SL. The impact of varicella vaccination on varicella-related hospitalization rates: global data review. Rev Paul Pediatr. 2016; 34 (3): 359-366.
Lau YL, Vessey SJ, Chan IS, Lee TL, Huang LM, Lee CY et al. A comparison of safety, tolerability and immunogenicity of Oka/Merck varicella vaccine and VARILRIX in healthy children. Vaccine. 2002; 20 (23-24): 2942-2949.
Marin M, Marti M, Kambhampati A, Jeram SM, Seward JF. Global varicella vaccine effectiveness: a meta-analysis. Pediatrics. 2016; 137 (3): e20153741.
Full text